Peptide record

TPDB46631

Antiviral standard
14 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB46631
Antiviral
Anti-infective peptides
Peptipedia
standard
No
A 14-aa standard-residue antiviral peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
NLEDLYSARGARGH
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C65H103N23O22
CQIKMFPTWV
ARGL
1558.67
7.77
3
2
5
+0
3.21
-1.029
70.00
Mammalian: 1.4 hour Yeast: 3 min E.coli: >10 hour
1490
0.96
3
Residue Composition
number
2
A
2
R
1
N
1
D
0
C
1
E
0
Q
2
G
1
H
0
I
2
L
0
K
0
M
0
F
0
P
1
S
0
T
0
W
1
Y
0
V
Amino Acid Distribution
A: 2 R: 2 N: 1 D: 1 C: 0 E: 1 Q: 0 G: 2 H: 1 I: 0 L: 2 K: 0 M: 0 F: 0 P: 0 S: 1 T: 0 W: 0 Y: 1 V: 0
Chemical Descriptors
14 reviewed residue count
C65H103N23O22 sequence-only estimate (linear, free termini)
1558.67 sequence-only estimate (linear, free termini)
7.77 sequence-only estimate (linear, free termini)
+0 sequence-only estimate (linear, free termini)
3.21 sequence-only estimate (linear, free termini)
-1.029 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA